Stephens Consulting, LLC Tg Therapeutics, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 40 shares of TGTX stock, worth $1,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$1,478% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
371Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$577 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$421 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$340 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$118 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$103 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.37B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...